🕵️ Conmed Corp ($CNMD)
SEC insider & ownership activity, last 12 months · CIK 816956 · every row links its SEC filing
Over the last 12 months insiders sold $300K with no open-market buying against it. Todd W. Garner sold $182K through a 10b5-1 trading plan in 2 lots (Aug–Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $300K (5 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Todd W. Garner | 0 | – | 2 | $182K | Nov 6, 2025 |
| Farkas Charles | 0 | – | 2 | $107K | Sep 12, 2025 |
| Glaze Richard | 0 | – | 1 | $11K | Nov 21, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 15.1% | 13G | Jul 18, 2025 | filing ↗ | |
| Vanguard Portfolio Management | 6.9% | 13G | Apr 29, 2026 | filing ↗ | |
| Fuller & Thaler Asset Management, Inc. | 5.6% | 13G | Aug 14, 2025 | filing ↗ | |
| Vanguard Capital Management | 5.2% | 13G | Apr 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Glaze Richard | $11K | Nov 21, 2025 | filing ↗ |
| Todd W. Garner | $150K | Nov 6, 2025 | filing ↗ |
| Farkas Charles | $107K | Sep 12, 2025 | filing ↗ |
| Todd W. Garner | $31K | Aug 7, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 17, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Material agreement (1.01) | May 27, 2026 | filing ↗ |
| New financial obligation (2.03) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 18, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 18, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing ↗ |
| Earnings (2.02) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 13, 2026 | filing ↗ |
| Earnings (2.02) | Jan 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 5, 2025 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 8, 2025 | filing ↗ |
| Other events (8.01) | Aug 7, 2025 | filing ↗ |
| Earnings (2.02) | Jul 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 30, 2025 | filing ↗ |